Try our Advanced Search for more refined results
Corporate
-
March 03, 2026
Ex-Morgan Stanley Adviser Guilty Of Defrauding NBA Clients
A Manhattan federal jury on Tuesday convicted a former Morgan Stanley investment adviser on fraud charges, for allegedly defrauding NBA player clients by overcharging them for life insurance investments and misappropriating funds.
-
March 03, 2026
Apollo Faces Class Action Over Alleged Epstein Business Ties
Apollo Global Management and its billionaire co-founders Leon Black and Marc Rowan have been hit with a proposed class action in New York federal court alleging they misled investors about the firm's and their individual connections to convicted sex offender Jeffrey Epstein.
-
March 03, 2026
Monthly Merger Review Snapshot
The U.S. Department of Justice got its antitrust case against Live Nation and Ticketmaster teed up for trial, as a court continues mulling the department's settlement last year in a case challenging a deal by Hewlett Packard Enterprise, and lawmakers call for scrutiny of Paramount Skydance's blockbuster acquisition of Warner Bros. Discovery.
-
March 03, 2026
Ex-Truth Social Exec Fights WaPo Defamation Suit Subpoena
A former executive of Truth Social's parent company told a North Carolina federal court Monday that Trump Media's last-minute bid to depose him in its high-profile defamation lawsuit against The Washington Post is actually a tactic to avoid sanctions in an unrelated lawsuit against him and other major media outlets.
-
March 03, 2026
Investor Claims Telecom CEO Faked Emails To Dilute Stake
The primary investor of a telecom infrastructure startup has accused its founder and a top executive in Delaware Chancery Court of forging board approvals, unlawfully issuing equity and sidelining the plaintiff in a bid to entrench control.
-
March 03, 2026
States Can't Duck Regeneron Counterclaims In FCA Case
Eleven states pursuing a False Claims Act case against Regeneron Pharmaceuticals over what they say were inflated reimbursements for an eye drug can't block counterclaims by the drugmaker on sovereign immunity grounds, a Massachusetts federal judge has ruled.
-
March 03, 2026
Paul Weiss Adds Kirkland M&A Partner To New Houston Shop
A month after launching a new Houston office, Paul Weiss Rifkind Wharton & Garrison LLP expanded the location with the addition of a corporate attorney who moved her practice from Kirkland & Ellis LLP.
-
March 03, 2026
1st Circ. Won't Revive Boston's Opioid Claims Against PBMs
Boston lost its bid to revive opioid crisis-related claims against two pharmacy benefit managers, as a First Circuit panel affirmed that the suit came years too late.
-
March 03, 2026
FTC Makes 'Significant Progress' In OptumRx, Caremark Talks
Federal Trade Commission staffers got more time Tuesday for settlement talks with OptumRx and Caremark that could end the agency's case accusing the pharmacy benefit managers of inflating insulin prices, with staffers citing considerable progress in the weeks since inking a deal with Express Scripts.
-
March 03, 2026
Live Nation Tells Jury It's A 'Fierce' But Legal Competitor
Live Nation does not illegally pressure concert venues or artists to use Ticketmaster and its other services, its counsel told a Manhattan federal jury Tuesday, calling the entertainment giant a "fierce, lawful, legitimate" competitor as a closely watched antitrust trial opened.
-
March 02, 2026
Ex-Google CEO Wins Stay Of Sexual Assault, Surveillance Suit
A woman who accused former Google CEO Eric Schmidt of sexually assaulting and surveilling her must arbitrate her claims, a Los Angeles state court judge ruled Monday after pressing the woman earlier in the day on whether the alleged surveillance, including the use of private investigators, amounted to sexual harassment.
-
March 02, 2026
FINRA Fines Goldman Subsidiary $1.3M Over Order Execution
The Financial Industry Regulatory Authority fined Goldman Sachs subsidiary Folio Investments Inc. $1.3 million for allegedly failing to properly review order execution quality after changing the market center through which it routed a substantial amount of its customer orders.
-
March 02, 2026
Ulta Case Judge Finds Wash. Antispam Law Constitutional
Weeks after a similar ruling across the state, another Washington federal judge has ruled that the state's antispam statute is constitutional and comports with U.S. law, allowing customers to move forward with their proposed class action accusing beauty retailer Ulta of bombarding shoppers with misleading email advertisements.
-
March 02, 2026
Bath & Body Works Brass Hid Growth Woes, Investor Claims
Current and former brass of personal care retailer Bath & Body Works face a shareholder derivative suit alleging they downplayed certain growth strategy flops, hurting the company and investors when disclosures of those fumbles caused share prices to slide.
-
March 02, 2026
Widower Drops Suit Over Disney Restaurant Allergy Death
A Florida lawsuit over a woman's food allergy death at a Walt Disney World restaurant has been voluntarily dismissed, likely ending a case in which Disney made an unusual attempt to send the case to arbitration pursuant to terms in its video streaming service.
-
March 02, 2026
SEC Drops Negligence Suit Against Ex-View CFO
The U.S. Securities and Exchange Commission agreed to dismiss with prejudice its negligence claim against a former chief financial officer of "smart" glassmaker View Inc., after the agency secured partial summary judgment on other claims in the case last year.
-
March 02, 2026
Apple Execs Hit With Derivative Suit Over Alleged Monopoly
A Florida police pension fund has hit Apple Inc.'s top brass with a derivative securities suit in California federal court, accusing them of breaching their fiduciary duties by profiting off of the company's anticompetitive conduct while exposing Apple to significant legal risks, which has already led to billions of dollars in fines.
-
March 02, 2026
Cable Industry Group Sues US Copyright Office Over Fees
The cable industry's main trade group is suing the U.S. Copyright Office, challenging an agency rule it says inflates the royalties cable providers must pay for carrying broadcast television by requiring them to report revenue they never actually receive.
-
March 02, 2026
Norfolk Investors Seek Class Cert. In Rail Safety Claims Suit
Investors suing Norfolk Southern and its top brass have asked a Georgia federal judge for class certification in a case alleging the railroad company made false claims about its safety culture and practices and deceived investors up until the fiery crash of one of the company's trains along the Ohio-Pennsylvania border in 2023.
-
March 02, 2026
Fla. REIT Blames Ponzi Probe, Lawsuits In Ch. 11 Filing
A real estate investment trust accused last year by Florida authorities of being a Ponzi scheme has filed for federal bankruptcy protection, claiming the state probe, a racketeering lawsuit from a talk show host and a U.S. Securities and Exchange Commission action tarnished its reputation.
-
March 02, 2026
NY Pushes Bid To Nix RealPage's Suit Over Rental Pricing Law
The Office of the New York State Attorney General once again has urged a New York federal court to dismiss a free speech suit filed by property management software company RealPage Inc., which is challenging a state law that prohibits landlords from using software that makes recommendations for things such as rents and occupancy levels.
-
March 02, 2026
Clifford Chance Adds UnitedHealth Group Deputy GC
Clifford Chance LLP has hired UnitedHealth Group Inc.'s former deputy general counsel, who is joining the Washington, D.C., team to work on antitrust issues related to transactions, litigation and compliance, the firm announced Monday.
-
March 02, 2026
The Top In-House Hires Of February
Legal department hires during the second month of 2026 included high-profile appointments at Walmart, Walgreens and the Big 12 Conference. Here, Law360 Pulse looks at some of the top in-house announcements from February.
-
March 02, 2026
Catching Up With Delaware's Chancery Court
The Delaware Chancery Court's docket last week featured headline-grabbing disputes involving fast food giant Jack in the Box and boxing legend Mike Tyson's cannabis venture, alongside high-stakes fights over merger documents, appraisal rights and a $75 million renewable energy funding clash.
-
March 02, 2026
Eggland's Best Must Face Suit Over 'Cage Free' Marketing
Eggland's Best must face a proposed class action from consumers alleging that the company deceptively markets its "cage free" eggs, an Illinois federal court ruled, finding the company has stated its hens enjoy more than just a cage-free environment.
Expert Analysis
-
Series
A Day In The In-House Life: Chime GC Talks Pathfinding
On a recent Tuesday in the office, Chime's general counsel Adam Frankel shares his typical work day, tackling everything from strategically guiding product launches and testing AI tools to mastering the perfect latte and making time for extracurricular interests.
-
How Shareholder Activism Fared In 2025
2025 was a turbulent yet transformative year in shareholder activism, and there are several key takeaways to help companies prepare for a 2026 that is shaping up to be even more lively, including increased focus on retail investors and the use of social media as a tool, say attorneys at Sidley.
-
Reviewing 2025's Artificial Intelligence Disputes Over IP
2025 brought the first major fair use rulings involving generative artificial intelligence, and in 2026 courts will weigh in on more discovery disputes, renewed motions to dismiss, class certification challenges and fair use defenses that could shape the course of future AI litigation, say attorneys at Debevoise.
-
Expect A New Normal In Commercial Real Estate This Year
Even amid office vacancies and a wave of loan maturities, the commercial real estate market isn't as volatile as one might expect heading into 2026, but market stress is still uniquely intersecting with broader business challenges, creating new opportunities for corporate counsel and other practitioners beyond real estate, says Mark Bell at Stinson.
-
Key Trends In Healthcare Antitrust In 2025
The healthcare industry braced for significant antitrust enforcement shifts last year driven by a change in administration, and understanding the implications of these trends is critical for healthcare organizations' risk management and strategic decision-making in the year ahead, say attorneys at Michael Best.
-
Preparing For Congressional Investigations In A Midterm Year
2026 will be a consequential year for congressional oversight as the upcoming midterm elections may yield bolder investigations and more aggressive state attorneys general coalitions, so companies should consider adopting risk management measures to get ahead of potential changes, say attorneys at Morgan Lewis.
-
Key Trends Shaping ESG And Sustainability Law In 2026
2025 saw a chaotic regulatory landscape and novel litigation around environmental, social and governance issues and sustainability — and 2026, while perhaps more predictable, will likely be no less challenging, with more lawsuits and a regulatory tug-of-war complicating compliance for global companies, say attorneys at Crowell.
-
How Bank M&A Prospects Brightened In 2025
Even with less-than-ideal macroeconomic conditions in 2025, federal banking regulators' shift away from procedural concerns to focus more on core financial risks boosted M&A in several key ways, including shorter review timelines and increased interest in de novo charters, say attorneys at Arnold & Porter.
-
3 Securities Litigation Trends To Watch In 2026
Pending federal appellate cases suggest that 2026 will be a significant year for securities litigation, with long-standing debates about class certification, new questions about the risks and value of artificial intelligence features, and private plaintiffs' growing role in cryptocurrency enforcement likely to be major themes, say attorneys at Willkie.
-
5 Tariff And Trade Developments To Watch In 2026
A new trade landscape emerged in 2025, the contours of which will be further defined by developments that will merit close attention this year, including a key ruling from the U.S. Supreme Court and a review of the U.S.-Mexico-Canada Agreement, says Ted Posner at Baker Botts.
-
Top 5 Antitrust Issues For In-House Counsel To Watch In 2026
With Trump administration enforcement policy having largely taken shape last year, antitrust issues that in-house counsel should have on the radar range from scrutiny of technology-assisted pricing to the return of merger remedies, say attorneys at Squire Patton.
-
Funding Haze And Deregulatory Pursuits: The CFPB In 2026
In 2025, the Consumer Financial Protection Bureau did not seek additional funding from the Federal Reserve and unwound the legacy of former bureau leadership, and this year will bring further efforts to rescind or rewrite bureau regulations, as well as a changed tone to supervision efforts, say attorneys at Covington.
-
4 Developments That Defined The 2025 Ethics Landscape
The legal profession spent 2025 at the edge of its ethical comfort zone as courts, firms and regulators confronted how fast-moving technologies and new business models collide with long-standing professional duties, signaling that the profession is entering a period of sustained disruption that will continue into 2026, says Hilary Gerzhoy at HWG Law.
-
Navigating AI In The Legal Industry
As artificial intelligence becomes an increasingly integral part of legal practice, Law360 guest commentary this year examined evolving ethical obligations, how the plaintiffs bar is using AI to level the playing field against corporate defense teams, and the attendant risks of adoption.
-
Regulatory Rollback And Lingering Limbo: The CFPB In 2025
The Consumer Financial Protection Bureau has implemented significant changes since President Donald Trump took office in January, including dismissing actions with prejudice, withdrawing guidance and rescinding rules, casting the bureau in uncertain light heading into 2026, say attorneys at Mayer Brown.